rnein, NSAD olarak bilinen ila grubunun sklkla kullanlmasnn mide hasarna yol at ve refl, gastrit ve lser gibi skntlar yannda getirebilecei bilinmektedir
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cazares H, Eberhart CG, et al
A., Walker, J
Liraglutide was found to activate osteoblast proliferation by promoting the Wnt signaling pathway and p-AMPK/PGC1 signaling pathway, and inhibit osteoclast activation by suppressing the OPG/RANKL/RANK signaling pathway through anti-inflammatory, antioxidant, and anti autophagic pathways, thereby reversing bone loss ( There are certain limitations of this study that should be noted
9 : e112797